Immune checkpoints, represented by cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed cell death protein 1 (PD-1) and its ligand 1 (PD-L1), are the most studied targets of immune escape through the negative regulation of T lymphocytes by tumor cells. This evidence concerns the gene PDCD1 and neoplasm.